APA

Di Lorenzo G., Pizza C., Autorino R., De Laurentiis M., Marano O., D'Alessio A., Cancello G., Altieri V., Tortora G., Perdonà S., Bianco A. R. & De Placido S. (20050301). Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. : European urology.

Chicago

Di Lorenzo Giuseppe, Pizza Carmine, Autorino Riccardo, De Laurentiis Michele, Marano Ombretta, D'Alessio Adele, Cancello Giuseppe, Altieri Vincenzo, Tortora Giampaolo, Perdonà Sisto, Bianco Angelo Raffaele and De Placido Sabino. 20050301. Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. : European urology.

Harvard

Di Lorenzo G., Pizza C., Autorino R., De Laurentiis M., Marano O., D'Alessio A., Cancello G., Altieri V., Tortora G., Perdonà S., Bianco A. R. and De Placido S. (20050301). Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. : European urology.

MLA

Di Lorenzo Giuseppe, Pizza Carmine, Autorino Riccardo, De Laurentiis Michele, Marano Ombretta, D'Alessio Adele, Cancello Giuseppe, Altieri Vincenzo, Tortora Giampaolo, Perdonà Sisto, Bianco Angelo Raffaele and De Placido Sabino. Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. : European urology. 20050301.